Jouault T, Delaunoy C, Sendid B, Ajana F, Poulain D
Unité INSERM 42, Domaine du CERTIA, Villeneuve d'Ascq, France.
Clin Diagn Lab Immunol. 1997 May;4(3):328-33. doi: 10.1128/cdli.4.3.328-333.1997.
Candida albicans mannan is the major cell wall antigen that elicits antibodies considered to be of little diagnostic value. It comprises epitopes corresponding to sequences of alpha- and beta-1,2-linked mannose residues. Both types of oligomannosidic epitopes may also be present on the glycosidic portions of other C. albicans molecules, i.e., mannoproteins (MP) (either structural or enzymatic) and glycolipids. The human humoral responses against beta-1,2- and alpha-linked oligomannosides were investigated by C. albicans Western blotting by considering the elective distribution of beta-1,2-oligomannosidic epitopes over a 14- to 18-kDa phospholipomannan (PLM) and the presence of alpha-mannosidic epitopes over heavily glycosylated MP. Western blotting of 51 control sera confirmed the presence of antibodies against C. albicans as a commensal member of the indigenous microflora; an immunoglobulin G (IgG) reactivity linked to enzyme-linked immunosorbent assay mannan signals was found for both PLM (beta-1,2-Man residues) and MP (alpha-Man residues). Despite strong reactivities against mannan and MP, IgG from 21 hospitalized patients with mycological evidence of deep-tissue invasion by C. albicans very significantly failed to react or reacted only faintly with PLM. This downregulation of anti-beta-1,2-oligomannosidic epitopes, associated with tissue invasion by C. albicans, was confirmed in 3 of 4 AIDS patients with extended oroesophageal candidosis. The application of a dissociation procedure proved that the absence of PLM reactivity was not due to the presence of immune complexes. These data provide the first evidence for a qualitative modification of the human antimannan antibody response associated with the C. albicans commensal-pathogenic transition.
白色念珠菌甘露聚糖是主要的细胞壁抗原,可引发被认为诊断价值不大的抗体。它包含与α-和β-1,2-连接的甘露糖残基序列相对应的表位。这两种低聚甘露糖表位也可能存在于其他白色念珠菌分子的糖苷部分,即甘露糖蛋白(MP)(结构型或酶型)和糖脂。通过白色念珠菌蛋白质免疫印迹法研究了人类对β-1,2-和α-连接的低聚甘露糖苷的体液反应,考虑到β-1,2-低聚甘露糖表位在14至18 kDa磷脂甘露聚糖(PLM)上的选择性分布以及α-甘露糖表位在高度糖基化的MP上的存在。对51份对照血清进行蛋白质免疫印迹证实了存在针对作为本土微生物群落共生成员的白色念珠菌的抗体;发现PLM(β-1,2-甘露糖残基)和MP(α-甘露糖残基)均存在与酶联免疫吸附测定甘露聚糖信号相关的免疫球蛋白G(IgG)反应性。尽管对甘露聚糖和MP有强烈反应性,但来自21名有白色念珠菌深部组织侵袭真菌学证据的住院患者的IgG与PLM反应非常显著地减弱或仅微弱反应。在4名患有广泛性食管念珠菌病的艾滋病患者中有3名证实了这种与白色念珠菌组织侵袭相关的抗β-1,2-低聚甘露糖表位的下调。解离程序应用证明PLM反应性缺失并非由于免疫复合物的存在。这些数据首次证明了与白色念珠菌共生-致病转变相关的人类抗甘露聚糖抗体反应的定性改变。